Siro Clinpharm buys German clinical research firm
Clinical research organisation Siro Clinpharm Pvt Ltd has acquired 100 per cent equity in Germany-based Omega Mediation Group in an all-cash deal, but for an undisclosed sum. The acquisition marks Siro Clinpharm's entry into Europe, said Dr Chetan Tamhankar, Chief Operating Officer, Siro Clinpharm. Omega has around 120 people, across its operations in Greece, Estonia and Israel. And there will be no change in the management or employee structure as the operations expand, he said.